Company: SYRA
Filing Date: 2025-03-11
Form Type: 10-K
Source: 0001493152-25-009873
Chunk: 462

Company: Syra Health Corp
Filing Date: 2025-03-11
Form: 10-K
Item: Item 2
Chunk 462
---
, 2024 and 2023
     
    F-4

    Statements of Stockholders’ Equity for the Years Ended December 31, 2024 and 2023
     
    F-5

    Statements of Cash Flows for the Years Ended December 31, 2024 and 2023
     
    F-6

    Notes to the Financial Statements
     
    F-7

F-1

REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To
the Board of Directors and

Stockholders
of Syra Health Corp.

Opinion
on the Financial Statements

We
have audited the accompanying balance sheets of Syra Health Corp. (the Company) as of December 31, 2024 and 2023, and the related statements
of operations, stockholders’ equity, and cash flows for each of the years in the two-year period ended December 31, 2024 and the
related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements referred to
above present fairly, in all material respects, the financial position of the Company as of December 31, 2024 and 2023, and the results
of its operations and its cash flows for each of the years in the two-year period ended December 31, 2024, in conformity with accounting
principles generally accepted in the United States of America.

Going
Concern

The
accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note
2 to the financial statements, the Company had a cash balance of $2,395,405, working capital of $2,739,246 and an accumulated deficit
of $8,824,193 since inception, which raises substantial doubt about its ability to continue as a going concern. Management’s plans
regarding those matters are discussed in Note 2. The financial statements do not include any adjustments that might result from the outcome
of this uncertainty.

Basis
for Opinion

These
financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s
financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board
(United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities
laws and the applicable rules and